CVR 54556314Public limited company (A/S)Udlejning af erhvervsejendomme (682040)GræstedFounded 12 Apr 1976
CVR holds no employment figures for this company.
Compiled by Dandex from the Danish Business Registry (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish Company Data. Connect it once and ask about PHARMATRADE EJENDOMME A/S, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set up DandexGross profit
25.6K
DKK, annual report 2016
-84% on 2015
Result
+153.7K
DKK, annual report 2016
Equity
296.3K
DKK, annual report 2016
PHARMA-TRADE A/SCVR 87339815, 100% of capital and votes, until 29 Dec 2017
Jan Overgaarduntil 7 Jul 2017
No current owner is registered.
Holders of 5% or more, from the owner register. CVR records shares in bands, not exact figures.
CVR 87339815100% of capital and votes1 Mar 2003 to 29 Dec 2017
PHARMATRADE EJENDOMME A/S holds no Danish company now.
Found by searching the CVR owner register (ejerregister) for PHARMATRADE EJENDOMME A/S as owner: Danish companies it holds 5% or more of, and their holdings one level down. Foreign holdings are not in CVR.
CVR 35225528100% of capital and votes30 Jun 2013 to 28 Dec 2017
Decided by Dandex with fixed rules from CVR and the filed annual reports, and for the auditor's report, the business model and the revenue model a calibrated decision model reading the report's text and the purpose clause, not registered by the company. Each label links to its definition.
CVR lists no current officers for this company.
12 Apr 1976 to 16 Nov 2026.
| Metric | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|
| Revenue | 300 | 300 | Not reported | Not reported | Not reported |
| Gross profit | Not reported | Not reported | 260 | 160 | 26 |
| Operating profit | +178 | -80 | +172 | -241 | -56 |
| Result for the year | +76 | -215 | -210 | +38 | +154 |
| Equity | 1,979 | 1,764 | 892 | 284 | 296 |
| Total assets | 4,249 | 15,582 | 14,704 | 13,728 | 12,122 |
| Credit metrics (Dandex calculations) | |||||
| Revenue growth (omsætningsvækst) | 0% | 0% | Not reported | Not reported | Not reported |
| EBIT margin (overskudsgrad) | 59.2% | -26.7% | Not reported | Not reported | Not reported |
| EBITDA | 266 | 9 | 260 | 160 | -56 |
| EBITDA margin (EBITDA-margin) | 88.8% | 2.9% | Not reported | Not reported | Not reported |
| Net interest-bearing debt (NIBD, nettorentebærende gæld)Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | ||||
| Gearing, NIBD / EBITDAPro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | Pro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | ||||
| Interest coverage (rentedækning)Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | ||||
| Adjusted equity ratio (justeret soliditetsgrad)Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | ||||
| ROIC (afkast af investeret kapital)Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | ||||
| Capex (investeringer i anlægsaktiver) | Not reportednote 1 | 0note 2 | Not reportednote 1 | Not reportednote 1 | Not reportednote 1 |
| Capex % of sales (investeringer i procent af omsætningen)Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | ||||
| FCFF / EBITDA (pengestrømskonvertering)Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | ||||
DKK thousands. Annual reports via XBRL.
Credit metrics are Dandex calculations from the filed figures, not filed values; estimates are in grey with a note. Ratios are percentages. Gearing and interest coverage are multiples. Rows marked Pro hold a value in the Pro plan. Definitions.
Annual report 2016
1 Jan 2016 to 31 Dec 2016, published 31 May 2017
Annual report 2015
1 Jan 2015 to 31 Dec 2015, published 21 Apr 2016
Annual report 2014
1 Jan 2014 to 31 Dec 2014, published 19 May 2015
Annual report 2013
1 Jan 2013 to 31 Dec 2013, published 14 May 2014
Annual report 2012
1 Jan 2012 to 31 Dec 2012, published 3 Jun 2013
No changes since Dandex began following this company. For announcements from before then, see Registrations.
Pro: Signals (signaler) are in the Pro plan, see pricingChanges worth a look, raised from the registry and new annual reports.
New leadership (nyt lederskab), New company (ny virksomhed), Ownership change (ejerskifte), Relocation (flytning), Growth surge (vækstspurt), Headcount decline (nedgang i ansatte), Restructuring (omstrukturering), Industry change (brancheskift), Board change (bestyrelsesændring), Dissolution (ophør), Distress warning (risikoadvarsel), Fund investment (fondsinvestering), Fund exit (fondsexit), Fund board seat (fondsbestyrelsespost).
The rows marked Pro on this page hold values in the Pro plan. For PHARMATRADE EJENDOMME A/S, that is:
Have Pro? Sign in to see the values on this page.
Each registered value from the day it took effect, newest first.
From CVR, read 16 Nov 2026. Text such as the signing rule and purpose is shown as registered.
From CVR, read 16 Nov 2026. A change is counted each time the registry records a new value, so a corrected address or an audit firm under a new entity counts too.
15 registrations, newest first. As published by Erhvervsstyrelsen, in Danish, with people's street addresses cut to postcode and city.
Likvidation sluttet, og virksomheden opløst
Likvidatorer:
Fratrådte:
Henrik Overgaard, den 29.12.2017.
Revision:
Fratrådte:
GRANT THORNTON,STATSAUTORISERET REVISIONSPARTNERSELSKAB, den 29.12.2017.
Likvidation vedtaget 07.07.2017
Likvidatorer:
Tiltrådte:
Henrik Overgaard, den 07.07.2017.
Bestyrelse:
Fratrådte:
Henrik Overgaard, den 07.07.2017, Ib Preben Overgaard, den 07.07.2017, Jan Overgaard, den 07.07.2017.
Direktion:
Fratrådte:
Jan Overgaard (adm. dir), den 07.07.2017.
Virksomheden tegnes af en likvidator.
Virksomhedens kreditorer opfordres til at anmelde deres krav til likvidator. Krav skal anmeldes senest tre måneder fra dags dato.
Ved kommunalreformen den 1. januar 2007 er hjemstedskommunen ændret.
Regnskabsår ændret til:
01.01 - 31.12.
Omlægningsperiode:
01.07.2002 - 31.12.2003.
Ny adresse:
Skaaremosevej 11, Blistrup, 3230 Græsted.
Vedtægter ændret:
14.08.2003.
Nyt navn:
PHARMATRADE EJENDOMME A/S.
Ny adresse:
Skaaremosevej 11-14, Blistrup, 3230 Græsted.
Ny kommune:
Græsted-Gilleleje.
Bestyrelse:
Udtrådt af bestyrelsen:
Jens Vagn Nielsen, Steen Honore Hansen, Karsten Kielland.
Indtrådt i bestyrelsen:
Fabrikant Ib Preben Overgaard, Fabrikant Jan Overgaard, Fabrikant Henrik Overgaard.
Direktion:
Udtrådt af direktionen:
Indtrådt i direktionen:
Fabrikant Jan Overgaard (adm.dir.).
Revision:
Udtrådt af revisionen:
EXANTE REVISION, REGISTRERET REVISIONSAKTIESELSKAB.
Indtrådt i revisionen:
KRESTEN FOGED STATSAUTORISERET REVISIONSAKTIESELSKAB, Frederiksgade 1, 1265 København K.
Vedtægter ændret:
25.09.1996.
Kapitalforhøjelse:
kr. 200.000,00 indbetalt ved overførte reserver / overskud, kurs 100,00.
Kapitalen udgør herefter kr. 500.000,00.
Vedtægter ændret:
21.12.1994.
Nyt navn:
M. T. N. INVEST A/S.
Vedtægter ændret:
27.11.1990
Kapitalforhøjelse kr. 220.000,00: kr. 20.000,00 indbetalt kontant, kurs 1500,0, kr. 200.000,00 indbetalt ved overførte reserver / overskud, kurs 100,0
Selskabet er omdannet til A/S198812
NAVN: SALOMON PROPOLIS A/S
ADRESSE: Frydensbergvej 21 A, 3660 Stenløse
Kommune:
Stenløse
Kapital kr. 300.000,00
Bestyrelse:
Direktør Benny Ole Grath, 2960 Rungsted Kyst, Direktør Mogens Axel Gelardi Kalsbøll, 2920 Charlottenl, Direktør Jens Vagn Nielsen, 3670 Veksø Sj
Direktion:
Direktør Jens Vagn Nielsen, 3670 Veksø Sj
Selskabet tegnes af en direktør eller af den
samlede bestyrelse.
Revision:
Revision Holbæk, 4300 Holbæk
Regnskabsår:
01.07 - 30.06
Vedtægter ændret:
04.12.1989
Regnskabsår ændret til:
01.07 - 30.06
Omlægningsperiode:
01.05.1988 - 30.06.1989
REG.NR. ApS13917
NAVN: SALOMON PROPOLIS ApS
ADRESSE: Frydensbergvej 21 A, 3660 Stenløse
Stiftelsesdato:
12.04.1976
Seneste vedtægtsdato:
21.11.1984
Kapital:
kr. 80.000,00
Indbetalingsmåde:
kontant/i værdier kr. 80.000,00 til kurs 100,0
Direktion:
Direktør Jens Vagn Nielsen
Selskabet tegnes af en direktør alene
Revision:
Revision Holbæk, 4300 Holbæk
Første regnskabsår:
00.00 - 00.00
Regnskabsår:
01.05 - 30.04
1 registered in CVR.
P-number 1002020523Skaaremosevej 11, 3230 Græsted